Actively Recruiting
Contoura With Phorcides Compared to Wavefront Optimized LASIK
Led by Daniel Terveen · Updated on 2023-04-26
120
Participants Needed
4
Research Sites
67 weeks
Total Duration
On this page
Sponsors
D
Daniel Terveen
Lead Sponsor
A
Alcon Research
Collaborating Sponsor
AI-Summary
What this Trial Is About
Comparing post-operative visual acuity and patient reported satisfaction between Contoura with Phorcides and WaveLight Wavefront Optimized.
CONDITIONS
Official Title
Contoura With Phorcides Compared to Wavefront Optimized LASIK
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients at least age 21 years of age undergoing LASIK eye surgery
- Willing and able to comprehend informed consent and complete 1 month post-op visit
- Potential postoperative BCDVA of 20/20 or better in each eye based on Investigator's medical opinion
- Candidates for Contoura with Phorcides (Myopic, astigmatism <3.0D)
- Both eyes targeted for plano
- Pre-operative total corneal Pachymetry 490um or above
- Stable refractive error <0.50D change in preceding year
- Good general and ocular health
- Pre-operative exam completed within three months of surgery
- SCL discontinued 3 days prior to pre-op exam and the procedure
- Pachymetry above 490 with residual greater than 270um
- Candidates who, as determined by the investigator, can safely undergo LASIK
You will not qualify if you...
- Patients under 21 years of age
- Concomitant ocular condition which would limit the BCVA at the discretion of the surgeon
- Patients with usual relative and absolute contraindications for LASIK surgery (Patients with severe dry eye, recurrent corneal erosion, uncontrolled Glaucoma, collagen vascular disorders, keratoconus or signs of keratoconus, uncontrolled Diabetes, Herpes)
- Pachymetry below 490
- Autoimmune or immunodeficiency diseases
- Pregnant or nursing women
- Patients with signs of inability to understand consent for study and procedure planned
- Patients with history of previous ocular surgery
- Patients with strabismus or amblyopia
- Patients that have a BCDVA of 20/25 or worse in either eye
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 4 locations
1
Vance Thompson Vison
Bozeman, Montana, United States, 57105
Actively Recruiting
2
Vance Thompson Vision
Omaha, Nebraska, United States, 57105
Actively Recruiting
3
Vance Thompson Vision
Fargo, North Dakota, United States, 57105
Actively Recruiting
4
Vance Thompson Vision
Sioux Falls, South Dakota, United States, 57108
Actively Recruiting
Research Team
D
Daniel Terveen, MD
CONTACT
E
Elise Meide, M.S.
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here